Bharat Seats Limited
NSE: BHARATSEMarket Closed • NSE
Day range
52 week range
Bharat Seats Limited closed at INR208.61 (-0.17%) on volume 0.18x its 20-day average, trading 20.73% below its 52-week high.
2026-Q1
Q1 FY2026 Financial Results
PAT moved +33.9% QoQ
2026-07-17
DIVIDEND Announced
Dividend - Rs 1.50 Per Share
2025-07-02
DIVIDEND Announced
Annual General Meeting/Dividend - Rs 1.10 Per Share
Revenue and PAT bars use independent scales to make their year-on-year direction readable.
Complete reported financial history · Values use the company's reporting currency
Hover over the chart for exact reported values. Percentage lines use the right-hand axis.
A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.
Strengths
Low Debt Profile: Debt-to-Equity is comfortable at 0.48x
High Cash Flow Conversion: CFO/PAT averaged 2.6x over last 3 years
Risks
Subject to cyclical raw material and macro industry pressures
Bull case
Market Leadership: Established operational scale in Auto Parts.
Bear case
Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.
Flip condition
Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.
Complete dividend, bonus, split, rights and other action history
| Record date | Corporate action | Information | Announcement date | Ex-date |
|---|---|---|---|---|
| 17 Jul 2026 | Dividend | ₹1.50 / share | — | 17 Jul 2026 |
| 02 Jul 2025 | Dividend | ₹1.10 / share | — | 02 Jul 2025 |
Traded volume and delivery percentage across the latest 20 sessions
Compare valuation, latest quarterly performance and year-on-year growth
| Company name | Market cap ₹ Cr | P/E ratio | Dividend yield % | Quarterly sales ₹ Cr | Profit after tax ₹ Cr | Sales growth % | Profit growth % |
|---|---|---|---|---|---|---|---|
 Titan Company LimitedTITAN Open analysis | ₹3.94L | 68.51 | 0.34% | ₹21,356.00 | ₹1,777.00 | +29.25% | +62.88% |
 Maruti Suzuki India LimitedMARUTI Open analysis | ₹3.61L | 25.20 | 1.22% | ₹52,470.00 | ₹3,447.00 | +35.92% | -9.10% |
Mahindra & Mahindra LimitedM&M Open analysis | ₹3.51L | 17.78 | 1.15% | ₹41,959.00 | ₹3,685.00 | +22.89% | +6.81% |
 Eternal LimitedETERNAL Open analysis | ₹3.00L | 692.13 | 0.00% | ₹3,349.00 | ₹585.00 | +38.79% | -2.82% |
Bajaj Auto LimitedBAJAJ-AUTO Open analysis | ₹2.86L | 24.74 | 1.44% | ₹17,243.72 | ₹2,982.84 | +36.35% | +34.94% |
 Eicher Motors LimitedEICHERMOT Open analysis | ₹2.00L | 34.66 | 1.13% | ₹6,632.00 | ₹1,463.00 | +31.54% | +21.41% |
 TVS Motor Company LimitedTVSMOTOR Open analysis | ₹1.95L | 56.76 | 0.30% | ₹16,296.00 | ₹1,058.00 | +33.46% | +64.54% |
 Samvardhana Motherson International LimitedMOTHERSON Open analysis | ₹1.70L | 38.55 | 0.31% | ₹35,244.00 | ₹1,076.00 | +16.66% | +77.56% |
Bharat Seats Limited manufactures and sells seating systems and interior components for the automotive and surface transport industries in India. It offers seats for four-wheeler, two-wheeler, and railways chair car; carpets; roof and windshield modeling products; and two-wheeler frame parts. The company was incorporated in 1986 and is based in Gurugram, India.
IndiaConsumer Cyclical
Is Bharat Seats Limited Shariah compliant?
Bharat Seats Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (8.4%) complies with AAOIFI threshold (≤ 33%).
What is Bharat Seats Limited's current valuation relative to peers?
Bharat Seats Limited trades at a P/E of 28.3x compared to the sector median of 26.8x, and a Price-to-Book of 5.7x.
Is the company financially healthy?
The company has a Debt-to-Equity ratio of 0.48x. Interest coverage is 6.4x.
What are the historical revenue and profit growth rates?
Over the past 5 years, revenue compounded at 14.2% while net profit growth averaged consistent levels.
Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.
Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.